You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HDAC inhibitor

Showing 1 - 25 of 7,551
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023

Cushing Disease Trial (Fimepinostat)

Not yet recruiting
  • Cushing Disease
  • (no location specified)
Jul 31, 2023

Peripheral T-cell Lymphoma Trial in Shanghai (PD-1 antibody+ HDAC inhibitor)

Recruiting
  • Peripheral T-cell Lymphoma
  • PD-1 antibody+ HDAC inhibitor
  • Shanghai, Shanghai, China
    Dongmei Ji
Dec 3, 2021

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))

Terminated
  • Hodgkin's Lymphoma
  • histone deacetylase inhibitor (ITF2357)
  • Milan, Italy
    Istituto Nazionale per lo studio e la cura dei Tumori
Jan 18, 2022

Circulating Tumor DNA-Guided Late-Line Treatment in Late-Stage

Completed
  • Metastatic Breast Cancer
  • +2 more
  • Control group
  • Case group
  • (no location specified)
Jun 16, 2022

Prostate Cancer, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer Trial in Baltimore, Buffalo (drug, other,

Terminated
  • Prostate Cancer
  • +4 more
  • Baltimore, Maryland
  • +1 more
Sep 30, 2022

Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Sodium Valproate
  • +2 more
  • Saint Leonards, New South Wales, Australia
  • +8 more
Jan 22, 2023

Recurrent Plasma Cell Myeloma Trial in Columbus (Dexamethasone, HDAC Inhibitor AR-42, Laboratory Biomarker Analysis)

Completed
  • Recurrent Plasma Cell Myeloma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jun 10, 2021

Malignant Solid Tumour Trial in San Antonio (Hydroxychloroquine, Vorinostat)

Active, not recruiting
  • Malignant Solid Tumour
  • San Antonio, Texas
    Cancer Therapy & Research Center University of Texas Health Scie
Dec 13, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Non Small Cell Lung Cancer Trial in Los Angeles, Boston, Fairfax (ACY-241, Nivolumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Los Angeles, California
  • +4 more
Nov 3, 2022

Metastatic Breast Cancer, Recurrent Ovarian Carcinoma Trial in Salt Lake City, Fairfax (Ribociclib, Belinostat)

Recruiting
  • Metastatic Breast Cancer
  • Recurrent Ovarian Carcinoma
  • Salt Lake City, Utah
  • +1 more
May 3, 2022

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Advanced Cancers Trial in Houston (Hydroxychloroquine, Sirolimus, Vorinostat)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2021

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Bortezomib, Dexamethasone)

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Mar 5, 2021

Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (JBI-802)

Recruiting
  • Locally Advanced Solid Tumor
  • Metastatic Solid Tumor
  • Denver, Colorado
  • +3 more
Aug 19, 2022

Extensive Stage Lung Small Cell Carcinoma, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States

Active, not recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • +2 more
  • Atezolizumab
  • +3 more
  • New York, New York
  • +4 more
Jul 16, 2022

Lymphoma, Follicular Trial in China (Abexinostat)

Recruiting
  • Lymphoma, Follicular
  • Beijing, China
  • +25 more
Mar 3, 2022

Breast Adenocarcinoma, Invasive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States (drug, biological, other)

Active, not recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Duarte, California
  • +4 more
Jul 16, 2022

Human Immunodeficiency Virus (HIV) Trial in New York, Aarhus, Cologne (3BNC117, Romidepsin)

Completed
  • Human Immunodeficiency Virus (HIV)
  • New York, New York
  • +2 more
Feb 3, 2021

Biliary Tract Cancer Trial in London (KA2507)

Withdrawn
  • Biliary Tract Cancer
  • London, United Kingdom
    Cancer Research UK and UCL Cancer Trials Centre
Jan 30, 2021

Cutaneous T-Cell Lymphoma Trial in United States (Panobinostat)

Terminated
Has Results
  • Cutaneous T-Cell Lymphoma
  • Birmingham, Alabama
  • +17 more
Aug 16, 2021

Melanoma Trial in New York (Mocetinostat Induction Phase + Ipilimumab + Nivolumab, Mocetinostat Maintenance Phase + Ipilimumab +

Terminated
  • Melanoma
  • Mocetinostat Induction Phase + Ipilimumab + Nivolumab
  • Mocetinostat Maintenance Phase + Ipilimumab + Nivolumab
  • New York, New York
    New York University School of Medicine
May 19, 2020